Physician profile
Harpreet Johl
NPI 1053423202
$1,074.73
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.74 · 2020: $50.42 · 2021: $290 · 2022: $259 · 2023: $228 · 2024: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $452 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $451.94 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $275.18 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $174.84 | 2019-2023 | Vaxneuvance, Gardasil 9, Pneumovax 23 |
| Abbott Laboratories | $148.49 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $77.54 | 2022-2024 | |
| Exact Sciences Corporation | $71.86 | 2023-2024 | Cologuard Collection Kit |
| Novo Nordisk INC | $60.74 | 2024 | Rybelsus, Ozempic |
| Alkermes, INC. | $47.56 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $40.48 | 2022-2024 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.23 | 2023-2024 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $31.85 | 2021-2023 | |
| Dexcom, INC. | $29.13 | 2024 | Dexcom G6 Transmitter |
| Medtronic, INC. | $24.22 | 2023 | Minimed 780g |
| Amgen INC. | $23.39 | 2024 | Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.08 | 2020 | |
| Lilly USA, LLC | $15.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harpreet Johl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.